Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence

被引:37
作者
Jirström, K
Ringberg, A
Fernö, M
Anagnostaki, L
Landberg, G [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Pathol, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Plast & Reconstruct Surg, S-20502 Malmo, Sweden
[3] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
关键词
breast cancer; DCIS; cell cycle; cyclin D1; recurrence; growth pattern;
D O I
10.1038/sj.bjc.6601398
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ductal carcinoma in situ (DCIS) of the breast constitutes about 10% of all diagnosed breast cancers and, despite surgical removal, it may recur, either as DCIS or invasive breast cancer. Nuclear grade and growth pattern according to Andersen et al as well as surgical margins are factors that have been used to predict local recurrence, but ideally a set of tumour-specific factors should be identified and used as prognostic markers. Many cell cycle regulatory gene products have been shown to be involved in the formation of tumours and are either oncogenes or suppressor genes and involved in key processes in the transformation. We therefore characterised the cell cycle regulators cyclin E, cyclin D1, p27 and p16 in a material of DCIS cases arranged in a tissue microarray. With a manual tissue arrayer, 52% of the initial 177 DCIS samples were successfully targeted allowing immunohistochemical analyses of all four proteins in 92 cases of DCIS. As also observed in invasive breast cancer, there was a trend indicating that DCIS cases with high cyclin D1 were cyclin E low and oestrogen receptor-positive, whereas cyclin E high DCIS cases were cyclin D1 low and oestrogen receptor-negative. For the 64 patients that did not receive postoperative radiotherapy, there were 16 local recurrences (eight DCIS and eight invasive breast cancer) during a mean follow-up time of 63 months. Cyclin E, p27 or p16 were not associated with local recurrence, but interestingly cyclin D1 was significantly and inversely associated with local recurrence, both using univariate and multivariate analyses. In summary, using a tissue array approach we have shown that cyclin D1, besides growth pattern, is a prognostic marker for local recurrence in DCIS.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 42 条
[21]   Regulation of the functional interaction between cyclin D1 and the estrogen receptor [J].
Lamb, J ;
Ladha, MH ;
McMahon, C ;
Sutherland, RL ;
Ewen, ME .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :8667-8675
[22]   The cyclin D1 high and cyclin E high subgroups of breast cancer:: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node [J].
Lodén, M ;
Stighall, M ;
Nielsen, HN ;
Roos, G ;
Emdin, SO ;
Östlund, H ;
Landberg, G .
ONCOGENE, 2002, 21 (30) :4680-4690
[23]   A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer [J].
Michalides, R ;
Hageman, P ;
vanTinteren, H ;
Houben, L ;
Wientjens, E ;
Klompmaker, R ;
Peterse, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (06) :728-734
[24]  
Nielsen NH, 1999, BREAST CANCER RES TR, V56, P105
[25]   Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein [J].
Nielsen, NH ;
Emdin, SO ;
Cajander, J ;
Landberg, G .
ONCOGENE, 1997, 14 (03) :295-304
[26]   Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ:: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status [J].
Oh, YL ;
Choi, JS ;
Song, SY ;
Ko, YH ;
Han, BK ;
Nam, SJ ;
Yang, JH .
PATHOLOGY INTERNATIONAL, 2001, 51 (02) :94-99
[27]   Analysis of Cdc2 and cyclin D1 expression in breast cancer by immunoblotting [J].
Ohta T. ;
Fukuda M. ;
Arima K. ;
Kawamoto H. ;
Hashizume R. ;
Arimura T. ;
Yamaguchi S. .
Breast Cancer, 1997, 4 (1) :17-24
[28]   Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiation [J].
Pardo, FS ;
Su, M ;
Borek, C .
SOMATIC CELL AND MOLECULAR GENETICS, 1996, 22 (02) :135-144
[29]  
RINGBERG A, 1991, EUR J SURG ONCOL, V17, P466
[30]   Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast [J].
Ringberg, A ;
Idvall, I ;
Fernö, M ;
Anderson, H ;
Anagnostaki, L ;
Boiesen, P ;
Bondesson, L ;
Holm, E ;
Johansson, S ;
Lindholm, K ;
Ljungberg, O ;
Östberg, G .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (05) :444-451